Are All Incretin Therapies Alike? Maximizing Treatment Potential for Patients With T2D

Are All Incretin Therapies Alike? Maximizing Treatment Potential for Patients With T2D

Program Goals

Patient Case

How to Individualize Glycemic Targets

ADA/EASD 2012 Recommendations for Antihyperglycemic Therapy

2013 AACE Glycemic Control Algorithm

Exenatide Twice Daily vs Basal Insulin Hypoglycemia

GLP-1 RAsEffects on Blood Pressure and Lipids

DPP-4 Inhibitors as Add-on Therapy to Basal Insulin (With or Without Oral Agents)

GLP-1 RAs vs DPP-4 Inhibitors Changes in HbA1c

GLP-1 RAs vs DPP-4 InhibitorsChanges in FPG